PSEN1 and Alzheimer disease: URMC-099 treatment significantly elevated PSD95 levels in AD mice compared to APP/PS1 (Fig. 8d, p < 0.01) and APP/PS1/vehicle (Fig. 8d, p < 0.05) mouse groups.